Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity

scientific article published on 6 January 2015

Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12020-014-0522-5
P932PMC publication ID4512568
P698PubMed publication ID25561371
P5875ResearchGate publication ID270455101

P50authorJoanna Jankiewicz-WikaQ64175250
Henryk StępieńQ66848136
Jacek ŚwiętosławskiQ90141594
Jolanta FryczakQ114426671
P2093author name stringJan Komorowski
Agnieszka Siejka
P2860cites workDiazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokininQ28574492
The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodentsQ32144736
Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brainQ33254281
Diazepam binding inhibitor (DBI): a peptide with multiple biological actionsQ34497484
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin releaseQ36445712
Gliotransmission and brain glucose sensing: critical role of endozepinesQ36635285
Minireview: Gut peptides: targets for antiobesity drug development?Q37210769
Much excitement about antidepressants, DBI and c-FOS.Q37891219
Peripheral signalling involved in energy homeostasis controlQ38061797
Molecular mechanisms of depression: perspectives on new treatment strategiesQ38111910
A new model of the role of psychological and emotional distress in promoting obesity: conceptual review with implications for treatment and prevention.Q38220436
Acute food deprivation reduces expression of diazepam-binding inhibitor, the precursor of the anorexigenic octadecaneuropeptide ODN, in mouse glial cellsQ43134813
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosaQ44312215
Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity.Q45901732
Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intakeQ48345403
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjectdiazepamQ210402
P304page(s)859-862
P577publication date2015-01-06
P1433published inEndocrineQ15757048
P1476titleReduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
P478volume49

Reverse relations

Q47179401What is the best size predictor for dose in the obese child?cites workP2860